Hudgens Stacie A, Cella David, Caprini Carol Ann, Caprini Joseph A
Center on Outcomes, Research and Education, Evanston Northwestern Healthcare, 1001 University Place, Suite 100, Evanston, Illinois 60201, USA.
Health Qual Life Outcomes. 2003 Dec 15;1:76. doi: 10.1186/1477-7525-1-76.
Deep vein thrombosis (DVT) is a serious health problem that affects more than 2 million people annually in the United States. Many of these patients develop asymptomatic DVT, but months to years later may experience symptomatic post-thrombotic syndrome (PTS). It is not known how many cases of PTS can be traced to "asymptomatic" DVT because venography is no longer routinely done and ultrasonography (US) may miss some asymptomatic clots. As a result, a clinical tool in addition to US to detect symptom emergence or exacerbation in patients after DVT would be of value.
Seventy-seven patients hospitalized with an acute DVT interviewed by telephone at 3-7 days, 30-40 days, and 12-months following discharge were included in this report. All were treated with a standard anticoagulation "Clinical Pathway Protocol" between April 1999 and January 2000. Using a 14-item Deep Vein Thrombosis Leg Symptom Index (DVT-LSI), patients were queried regarding leg pain, swelling, skin discoloration, cosmetic appearance, activity tolerance, emotional distress, and leg-related sleep problems.
The DVT-LSI for each leg was reliable at all assessments, with instrument reliability (alpha coefficients) greater than 0.70 at all time points (range 0.71-0.87). DVT-LSI scores, and the percentage of patients exhibiting symptoms, were higher in the DVT-affected leg at all time points. Among patients with unilateral disease, symptom severity ratings were significantly worse for patients in the affected leg compared to the normal leg at all time points, with the exception of those with a right-leg DVT at 12 months. Patients with bilateral thrombi did not have different scores on one leg compared to the other.
The DVT-LSI is useful in assessing symptomatic clinical outcomes in patients after diagnosis of DVT, and may represent a surrogate marker for DVT otherwise presumed to be asymptomatic.
深静脉血栓形成(DVT)是一个严重的健康问题,在美国每年影响超过200万人。这些患者中有许多人发生无症状性DVT,但数月至数年后可能会出现有症状的血栓形成后综合征(PTS)。由于静脉造影不再常规进行,超声检查(US)可能会遗漏一些无症状性血栓,因此尚不清楚有多少PTS病例可追溯到“无症状”DVT。因此,除US外,一种用于检测DVT后患者症状出现或加重的临床工具将具有重要价值。
本报告纳入了77例急性DVT住院患者,在出院后3 - 7天、30 - 40天和12个月通过电话进行访谈。所有患者在1999年4月至2000年1月期间均接受了标准抗凝“临床路径方案”治疗。使用14项深静脉血栓形成腿部症状指数(DVT-LSI),询问患者有关腿部疼痛、肿胀、皮肤变色、外观、活动耐力、情绪困扰以及与腿部相关的睡眠问题。
在所有评估中,每条腿的DVT-LSI均可靠,在所有时间点仪器可靠性(α系数)均大于0.70(范围0.71 - 0.87)。在所有时间点,DVT-LSI评分以及出现症状的患者百分比在受DVT影响的腿部更高。在单侧疾病患者中,除了12个月时右下肢DVT患者外,在所有时间点,患侧腿部患者的症状严重程度评分均显著高于正常腿部。双侧血栓形成患者的两条腿得分没有差异。
DVT-LSI有助于评估DVT诊断后患者的有症状临床结局,并且可能代表原本被认为无症状的DVT的替代标志物。